Hi-Tech Pharmacal (HITK) Reports Mixed Q3 Earnings

Hi-Tech Pharmacal Co., Inc. (NASDAQ: HITK) reports Q3 EPS of $0.18, 1 cent lower than the analyst estimate of $0.19. Revenues for the quarter were $29.4 million, versus the consensus of $27.20 million.

You May Also Be Interested In

• UPDATE: Bristow Group (BRS) Reports Better-Than-Expected Q4 Results; Offers FY13 Outlook
• Patterson Companies, Inc. (PDCO) Tops Q4 EPS by 5c; Guides FY12
• UPDATE: NetApp, Inc. (NTAP) Tops Q4 EPS by 3c; Guides Q1 Lower

Create E-mail Alert Related Categories

Earnings

Add Your Comment

Name

Subject

Body

Verification can't see the text?
click here to refresh the image.
what's this?

Follow StreetInsider.com On Twitter